Navigation Links
At 30, biotech is an industry at a crossroads

So just how old is the biotech industry? The July 2006 edition of MedAd News sustains that the industry has hit its 30th birthday this year. On Aug, 23, 2004, I wrote an article for this publication on "The Birth of Biotech: San Francisco, Boston, Geneva, or Chicago?"

In this ar......

Full article >>> llion, which grew 18 percent over the prior year (remember that the entire pharmaceutical industry grew 7 percent last year, and 5 percent in North America).
  • Losses of $4.3 billion, which decreased 30 percent from the prior year.
  • 32 new product approvals in the U.S., including 17 first-time approvals.
  • The second highest year for raising capital......

    Full article >>> companies.
  • Focus of cancer drugs on tumor types rather than tumor location: This dynamic is changing treatment modality in oncology. There are over 400 cancer drugs in development, and this development is changing how oncology clinical trials are being conducted. For example, it is not enough to say a patient has lung cancer today, as there are two broad types of lung can......

    Full article >>> nentech (U.S. - 1976)$6,633+44%$1,279+63%3. Genzyme (U.S. - 1981 )$2,735+24%$442+408%4. Serono (Switzerland - 1906 )**$2,586+5%<$105>N/A5. CSL (Australia - 1961)**$2,494+77%$419+149%6.......

    Full article >>> td>+49%22.Enzon Pharmaceuticals (U.S. - 1981)$166<2%><$90>N/A23.Vertex Pharmaceuticals (U.S. - 1989)$161+56%<$203><22%>24.Amylin Pharmaceuticals (U.S. - 1987)$141+315%<$207><32%>25.Berna Biotech (Switzerland - 1898)**
    Full article >>> 006

    Clearly, Amgen and Genentech are spending prodigious R&D sums, comparable to Big Pharma levels, but the next 3 yo 4 companies are not too far behind. This R&D is the life blood of a biotech company.

    All of the above trends noted by MedAd News really only focus on the drug part of biotech. As a result, I would add the following trends:



    Source:wistechnology.com By Michael Rosen 08/01/06


    Related biology technology :

    1. The state of global biotech: An Ernst & Young perspective
    2. Olympics of biotechnology has international flavor
    3. Getting noticed in Genetown: Wisconsin biotech on display
    4. Madison biotech NimbleGen files for IPO; one of states best-funded firms
    5. Wisconsin biotech firm receives $107K NIH grant
    6. Manufacturing partnership will move into biotech and biomedical spaces
    7. Wisconsin wont get Georgia biotech without a fight
    8. The 10 biggest events shaping biotech in 2006
    9. NimbleGen partners with UK biotech firm
    10. 2006: A great biotech financing year, unless you were going public!
    11. Big pharma seeks Wisconsin biotech partnerships
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:4/29/2016)... TURIN, Italy , April 29, 2016 ... version 5.11, the latest update to its industry-leading treatment ... has shown that Monaco version ... Users can now attain calculation speeds up to four ... Monaco . With the industry,s gold standard ...
    (Date:4/28/2016)... Q BioMed Inc. (OTCQB:QBIO), ...  was featured in an article he wrote on ... To Tread: http://www.lifescienceleader.com/doc/accelerators-enter-when-vcs-fear-to-tread-0001 ... an essential business journal for life science executives ... Big Pharmas. Their content is designed to inform ...
    (Date:4/28/2016)... ... April 28, 2016 , ... ... deliver a talk on its first-in-class technologies for tissue stem cell counting and ... on RNAiMicroRNA Biology to Reprogramming & CRISPR-based Genome Engineering in Burlington, Massachusetts. , ...
    (Date:4/28/2016)... ... April 28, 2016 , ... ... an open house for regional manufacturers at its Maple Grove, Minnesota technical center, ... Hardinge Group, Chiron and Trumpf. Almost 20 leading suppliers of tooling, accessories, ...
    Breaking Biology Technology:
    (Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
    (Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
    (Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
    Breaking Biology News(10 mins):